CHAPTER 103
SB 332 - FINAL VERSION
02/15/2018 0418s
2018 SESSION
18-2723
01/04
SENATE BILL 332
AN ACT relative to medication synchronization.
SPONSORS: Sen. Gray, Dist 6; Sen. Carson, Dist 14; Sen. Soucy, Dist 18; Sen. Fuller Clark, Dist 21; Sen. Hennessey, Dist 5; Rep. Kotowski, Merr. 24; Rep. LeBrun, Hills. 32; Rep. J. Edwards, Rock. 4; Rep. M. MacKay, Hills. 30; Rep. Bove, Rock. 5
COMMITTEE: Health and Human Services
─────────────────────────────────────────────────────────────────
AMENDED ANALYSIS
This bill requires insurers offering health insurance policies with prescription drug coverage to allow covered persons to synchronize the dispensing dates of their prescription drugs.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
02/15/2018 0418s 18-2723
01/04
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Eighteen
AN ACT relative to medication synchronization.
Be it Enacted by the Senate and House of Representatives in General Court convened:
103:1 New Section; Medication Synchronization. Amend RSA 415 by inserting after section 26 the following new section:
415:27 Medication Synchronization.
I. An individual or group health insurance plan or policy providing prescription drug coverage in New Hampshire, shall permit and apply a prorated, daily cost-sharing rate to covered prescriptions for a chronic condition that are dispensed by an in-network pharmacy for less than a 30-day supply if the prescriber and pharmacist determine the fill or refill to be in the best interest of the patient for the management or treatment of a chronic, long-term care condition and the patient requests or agrees to less than a 30-day supply for the purpose of synchronizing the patient's medications. For the purposes of this paragraph, the insured's or enrollee's maintenance prescription drugs to be synchronized shall meet all of the following requirements:
(a) They are covered by the policy, certificate, or contract described in this chapter.
(b) They are used for the management and treatment of a chronic, long-term care condition and have authorized refills that remain available to the insured or enrollee.
(c) Except as otherwise provided in this paragraph, they are not a controlled substance included in schedules II-V.
(d) They meet all utilization management requirements specific to the maintenance-prescription drugs at the time of the request to synchronize the insured's or enrollee's multiple, maintenance-prescription drugs.
(e) They are of a formulation that can be effectively split over required short-fill periods to achieve synchronization.
(f) They do not have quantity limits or dose-optimization criteria or requirements that will be violated when synchronizing the insured's or enrollee's multiple, maintenance-prescription drugs.
II. The plan or policy described in paragraph I shall apply a prorated, daily cost-sharing rate for maintenance-prescription drugs that are dispensed by an in-network pharmacy for the purpose of synchronizing the insured's or enrollee's multiple, maintenance-prescription drugs.
III. The plan or policy described in paragraph I shall not reimburse or pay any dispensing fee that is prorated. The insurer shall only pay or reimburse a dispensing fee that is based on each maintenance-prescription drug dispensed.
IV. A synchronization shall only occur once per year per maintenance-prescription drug.
103:2 New Section; Medication Synchronization; Managed Care Plan. Amend RSA 420-J by inserting after section 18 the following new section:
420-J:19 Medication Synchronization.
I. An individual or group health insurance plan or policy providing prescription drug coverage in New Hampshire, shall permit and apply a prorated, daily cost-sharing rate to covered prescriptions for a chronic condition that are dispensed by an in-network pharmacy for less than a 30-day supply if the prescriber and pharmacist determine the fill or refill to be in the best interest of the patient for the management or treatment of a chronic, long-term care condition and the patient requests or agrees to less than a 30-day supply for the purpose of synchronizing the patient's medications. For the purposes of this paragraph, the insured's or enrollee's maintenance prescription drugs to be synchronized shall meet all of the following requirements:
(a) They are covered by the policy, certificate, or contract described in this chapter.
(b) They are used for the management and treatment of a chronic, long-term care condition and have authorized refills that remain available to the insured or enrollee.
(c) Except as otherwise provided in this paragraph, they are not a controlled substance included in schedules II-V.
(d) They meet all utilization management requirements specific to the maintenance-prescription drugs at the time of the request to synchronize the insured's or enrollee's multiple, maintenance-prescription drugs.
(e) They are of a formulation that can be effectively split over required short-fill periods to achieve synchronization.
(f) They do not have quantity limits or dose-optimization criteria or requirements that will be violated when synchronizing the insured's or enrollee's multiple, maintenance-prescription drugs.
II. The plan or policy described in paragraph I shall apply a prorated, daily cost-sharing rate for maintenance-prescription drugs that are dispensed by an in-network pharmacy for the purpose of synchronizing the insured's or enrollee's multiple, maintenance-prescription drugs.
III. The plan or policy described in paragraph I shall not reimburse or pay any dispensing fee that is prorated. The insurer shall only pay or reimburse a dispensing fee that is based on each maintenance-prescription drug dispensed.
IV. A synchronization shall only occur once per year per maintenance-prescription drug.
103:3 Effective Date. This act shall take effect January 1, 2019.
Approved: May 25, 2018
Effective Date: January 01, 2019
| Date | Body | Type |
|---|---|---|
| Jan. 9, 2018 | Senate | Hearing |
| Feb. 15, 2018 | Senate | Floor Vote |
| March 27, 2018 | House | Hearing |
| April 11, 2018 | House | Exec Session |
| House | Floor Vote | |
| April 19, 2018 | House | Floor Vote |
May 25, 2018: Signed by the Governor on 05/25/2018; Chapter 0103; Effective 01/01/2019
May 25, 2018: Signed by the Governor on 05/25/2018; Chapter 0103; Effective 01/01/2019
April 26, 2018: Enrolled (In recess 04/26/2018); SJ 15
April 26, 2018: Enrolled 04/26/2018
April 19, 2018: Ought to Pass: MA VV 04/19/2018 HJ 13 P. 3
: Committee Report: Ought to Pass (Vote 19-0; CC)
April 19, 2018: Committee Report: Ought to Pass for 04/19/2018 (Vote 19-0; CC) HC 15 P. 4
April 11, 2018: Executive Session: 04/11/2018 01:15 PM LOB 302
April 4, 2018: Subcommittee Work Session: 04/04/2018 01:15 PM LOB 302
March 27, 2018: Public Hearing: 03/27/2018 10:30 AM LOB 302
March 7, 2018: Introduced 03/07/2018 and referred to Commerce and Consumer Affairs HJ 7 P. 50
Feb. 15, 2018: Ought to Pass with Amendment 2018-0418s, MA, VV; OT3rdg; 02/15/2018; SJ 4
Feb. 15, 2018: Committee Amendment # 2018-0418s, AA, VV; 02/15/2018; SJ 4
Feb. 15, 2018: Committee Report: Ought to Pass with Amendment # 2018-0418s, 02/15/2018; Vote 5-0; CC; SC 7
Jan. 9, 2018: Hearing: 01/09/2018, Room 101, LOB, 01:00 pm; SC 48
Jan. 3, 2018: To Be Introduced 01/03/2018 and Referred to Health and Human Services; SJ 1